Literature DB >> 6205277

Human T-cell leukaemia virus is not lysed by human serum.

H Hoshino, H Tanaka, M Miwa, H Okada.   

Abstract

Retroviruses isolated from avian, feline, murine and simian sources have been found to be inactivated and lysed by normal human serum. There is much evidence that complement is activated directly by retroviruses in the absence of antibody. Thus, human complement is thought to function as a natural defence mechanism against horizontal infection by retroviruses. Recently, a novel retrovirus, human T-cell leukaemia virus (HTLV), has been shown to be associated with adult T-cell leukaemia/lymphoma (ATL). A large number of healthy adults in south-west Japan, the West Indies and Africa carry antibodies against HTLV and these seropositive individuals are considered to be carriers of HTLV. Thus, horizontal spread of HTLV occurs frequently among humans. We set out to determine whether HTLV reacts with human complement, and report here that, unlike other animal retroviruses, HTLV is not lysed by normal human serum--this might explain the infectivity and persistence of HTLV in humans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205277     DOI: 10.1038/310324a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  17 in total

1.  Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation.

Authors:  Y Takeuchi; S H Liong; P D Bieniasz; U Jäger; C D Porter; T Friedman; M O McClure; R A Weiss
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Development of retroviral vectors as safe, targeted gene delivery systems.

Authors:  W H Günzburg; B Salmons
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

3.  Effect of heat and fresh human serum on the infectivity of human T-cell lymphotropic virus type III evaluated with new bioassay systems.

Authors:  S Harada; H Yoshiyama; N Yamamoto
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

Review 4.  Cellular immunology of HIV-infection.

Authors:  G P Spickett; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

Review 5.  Complement-related proteins in pathogenic organisms.

Authors:  Z Fishelson
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.

Authors:  Y Takeuchi; F L Cosset; P J Lachmann; H Okada; R A Weiss; M K Collins
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120.

Authors:  P L Nara; W G Robey; M A Gonda; S G Carter; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  Foamy virus vectors.

Authors:  D W Russell; A D Miller
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Characteristics and clinical significance of a stabilization assay to detect specific antibodies to reverse transcriptase of human immunodeficiency virus.

Authors:  M Morita; T Suzuki; K Nakajima; C Shiozawa; M J Gill; H Hoshino
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

10.  Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis.

Authors:  G T Spear; B L Sullivan; D M Takefman; A L Landay; T F Lint
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.